[go: up one dir, main page]

MX9203439A - Una citocina mamifera, il-11 - Google Patents

Una citocina mamifera, il-11

Info

Publication number
MX9203439A
MX9203439A MX9203439A MX9203439A MX9203439A MX 9203439 A MX9203439 A MX 9203439A MX 9203439 A MX9203439 A MX 9203439A MX 9203439 A MX9203439 A MX 9203439A MX 9203439 A MX9203439 A MX 9203439A
Authority
MX
Mexico
Prior art keywords
mammalian cytokine
cells involved
cytokine
stimulating
processes
Prior art date
Application number
MX9203439A
Other languages
English (en)
Inventor
Yu-Chung Yang
Frances K Bennett
Stephan R Paul
Original Assignee
Genetics Inst
Children S Medical Center C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Inst, Children S Medical Center C filed Critical Genetics Inst
Publication of MX9203439A publication Critical patent/MX9203439A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2073—IL-11
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5431—IL-11
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MX9203439A 1989-11-22 1990-11-20 Una citocina mamifera, il-11 MX9203439A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44110089A 1989-11-22 1989-11-22
US07/526,474 US5215895A (en) 1989-11-22 1990-05-21 Dna encoding a mammalian cytokine, interleukin-11
PCT/US1990/006803 WO1991007495A1 (en) 1989-11-22 1990-11-20 A mammalian cytokine, il-11

Publications (1)

Publication Number Publication Date
MX9203439A true MX9203439A (es) 1992-08-01

Family

ID=27032674

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9203439A MX9203439A (es) 1989-11-22 1990-11-20 Una citocina mamifera, il-11

Country Status (13)

Country Link
US (4) US5215895A (es)
EP (1) EP0504177B1 (es)
JP (2) JP2688539B2 (es)
KR (1) KR970005050B1 (es)
AT (1) ATE199096T1 (es)
CA (1) CA2069428C (es)
DE (1) DE69033700T2 (es)
DK (2) DK0504177T3 (es)
ES (1) ES2156852T3 (es)
GR (1) GR3035627T3 (es)
HU (1) HU215233B (es)
MX (1) MX9203439A (es)
WO (1) WO1991007495A1 (es)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215895A (en) * 1989-11-22 1993-06-01 Genetics Institute, Inc. Dna encoding a mammalian cytokine, interleukin-11
AU651152B2 (en) * 1990-08-29 1994-07-14 Genetics Institute, Llc Multidomain hematopoiesis stimulators
JP2752819B2 (ja) * 1990-11-08 1998-05-18 三共株式会社 新規サイトカイン
DE69233022T2 (de) 1991-11-04 2004-02-12 Genetics Institute, LLC, Cambridge Rekombinante knochenmorphogenetische protein heterodimere, zusammensetzungen und verfahren zur verwendung
US5460810A (en) * 1992-09-02 1995-10-24 Genetics Institute, Inc. Method for maintaining gut epithelial cells by treatment with a cytokine such as interleukin 11
US5602301A (en) 1993-11-16 1997-02-11 Indiana University Foundation Non-human mammal having a graft and methods of delivering protein to myocardial tissue
US5795569A (en) * 1994-03-31 1998-08-18 Amgen Inc. Mono-pegylated proteins that stimulate megakaryocyte growth and differentiation
DK0690127T3 (da) * 1994-03-31 1999-05-03 Amgen Inc Sammensætninger og fremgangsmåder til stimulering af megakaryocytvækst og -differentiering
US6270757B1 (en) * 1994-04-21 2001-08-07 Genetics Institute, Inc. Formulations for IL-11
US5582821A (en) * 1994-07-22 1996-12-10 Genetics Institute, Inc. Methods for treating bleeding disorders
US6274547B1 (en) * 1996-06-14 2001-08-14 Genetics Institute, Inc. Methods comprising the use of human interleukin-11 receptor proteins
DK0797664T3 (da) 1994-12-22 2007-01-22 Genetics Inst Llc Anvendelse af en human interleukin-11-receptor
US5760189A (en) * 1995-06-02 1998-06-02 Genetics Institute, Inc. Protein recovery & purification methods
US5824789A (en) * 1995-06-07 1998-10-20 Systemix, Inc. Human growth factors, nucleotide sequence encoding growth factors, and method of use thereof
JPH11507663A (ja) * 1995-06-09 1999-07-06 イエダ リサーチ アンド デベロツプメント カンパニー リミテツド レストリクチンｐ／アクチビンａを含む薬学的組成物及びｉｌ−６及び／又はｉｌ−１１のアンタゴニストとしてのその用途
US5679339A (en) * 1995-06-27 1997-10-21 Keith; James Method of using IL-11 for treating spondyloarthropies
US6126933A (en) * 1995-06-27 2000-10-03 Genetics Institute Methods of treating inflammatory bowel diseases by administering IL-11
US6540993B1 (en) * 1995-06-27 2003-04-01 Wyeth Method of treating inflammatory bowel disease using a topical formulation of IL-11
US6887461B1 (en) 1998-10-26 2005-05-03 Genetics Institute, Llc Method of using IL-11 for treating mucositis
US5686246A (en) * 1995-08-03 1997-11-11 Kornman; Kenneth S. Detecting genetic predisposition to periodontal disease
EP0871472A4 (en) * 1995-10-27 2001-05-30 Amrad Operations Pty Ltd CYTOKINS AND THEIR USE IN TREATMENT AND / OR PREVENTION OF BREAST CANCER
KR100426286B1 (ko) * 1996-01-09 2004-06-30 주식회사 엘지생명과학 효모를이용한인간인터루킨-11의제조방법
AUPO439396A0 (en) 1996-12-24 1997-01-23 Walter And Eliza Hall Institute Of Medical Research, The A method of treatment and prophylaxis
AU764292B2 (en) * 1998-01-23 2003-08-14 Genetics Institute, Llc Method of using IL-11 to enhance cell mediated immunity for treating various viral and parasitic infections and cancer
CA2237915A1 (en) 1998-05-19 1999-11-19 Stephen Shaughnessy Osteoporosis treatment
US6265165B1 (en) * 1998-11-12 2001-07-24 The Regents Of The University Of California Methods for EST-specific full length cDNA cloning
AU3738300A (en) * 1999-03-11 2000-09-28 Genetics Institute Inc. Use of interleukin-11 to prevent immune-mediated cytotoxicity
US6953777B2 (en) * 1999-03-11 2005-10-11 Genetics Indtitute LLC Use of interleukin-11 to prevent immune-mediated cytotoxicity
EP1096948A4 (en) * 1999-04-15 2004-04-07 Inst Genetics Llc USE OF INTERLEUKIN-11 FOR TREATING GASTROINTESTINAL DISEASES
US6274135B1 (en) * 1999-06-22 2001-08-14 Genetics Institute, Inc. Method of using IL-11 for inflammation associated with acute pancreatitis
EP1368486A4 (en) * 1999-07-15 2009-04-01 Genetics Inst Llc IL-11 FORMULATIONS
WO2003049693A2 (en) * 2001-12-06 2003-06-19 Wyeth Method and composition for inducing weight loss
US6982080B2 (en) * 2002-03-15 2006-01-03 Wyeth Hydroxyethyl starch—containing polypeptide compositions
US20040126358A1 (en) * 2002-09-16 2004-07-01 Warne Nicholas W. Delayed release formulations for oral administration of a polypeptide therapeutic agent and methods of using same
EP1675608B1 (en) 2003-09-12 2007-03-21 Wyeth Injectable calcium phosphate solid rods for delivery of osteogenic proteins
WO2005085283A1 (ja) * 2004-03-03 2005-09-15 Yamanouchi Pharmaceutical Co., Ltd. 修飾インターロイキン−１１及びそれを含有する医薬組成物
WO2006081379A1 (en) * 2005-01-26 2006-08-03 Wyeth Use of sfrps as markers of bmp activity
JP2009518418A (ja) * 2005-12-06 2009-05-07 ワイス インターロイキン１１組成物および使用法
US20080069796A1 (en) * 2006-07-31 2008-03-20 Kim Jong-Mook Low Dose Treatment with an Interleukin-11 Analog
WO2011151716A1 (en) 2010-06-04 2011-12-08 Lupin Limited Process for the purification of recombinant human il-11
EP2625264B1 (en) 2010-10-08 2022-12-07 Terumo BCT, Inc. Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
US9320777B2 (en) 2011-05-13 2016-04-26 Bolder Biotechnology, Inc. Methods and use of growth hormone supergene family protein analogs for treatment of radiation exposure
WO2015073918A1 (en) 2013-11-16 2015-05-21 Terumo Bct, Inc. Expanding cells in a bioreactor
WO2015148704A1 (en) 2014-03-25 2015-10-01 Terumo Bct, Inc. Passive replacement of media
WO2016049421A1 (en) 2014-09-26 2016-03-31 Terumo Bct, Inc. Scheduled feed
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
US11229683B2 (en) 2015-09-18 2022-01-25 Bolder Biotechnology, Inc. Hematopoietic growth factor proteins and analogs thereof and angiotensin converting enzyme inhibitors for treatment of radiation exposure
US11965175B2 (en) 2016-05-25 2024-04-23 Terumo Bct, Inc. Cell expansion
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
CN110382524B (zh) * 2017-01-16 2024-02-06 南沙生物科技(香港)公司 用于在酵母中生产重组il-11的系统和方法
EP3656841A1 (en) 2017-03-31 2020-05-27 Terumo BCT, Inc. Cell expansion
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
WO2022204315A1 (en) 2021-03-23 2022-09-29 Terumo Bct, Inc. Cell capture and expansion
US12152699B2 (en) 2022-02-28 2024-11-26 Terumo Bct, Inc. Multiple-tube pinch valve assembly

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863727A (en) * 1986-04-09 1989-09-05 Cetus Corporation Combination therapy using interleukin-2 and tumor necrosis factor
US5215895A (en) * 1989-11-22 1993-06-01 Genetics Institute, Inc. Dna encoding a mammalian cytokine, interleukin-11
US5371193A (en) * 1990-05-21 1994-12-06 Genetics Institute, Inc. - Legal Affairs Mammalian cytokine, IL-11
JPH0571866A (ja) * 1991-09-17 1993-03-23 Matsushita Refrig Co Ltd 断熱箱体

Also Published As

Publication number Publication date
HU215233B (hu) 1998-11-30
ATE199096T1 (de) 2001-02-15
HUT64595A (en) 1994-01-28
DK66692A (da) 1992-07-22
US5700664A (en) 1997-12-23
JP2783361B2 (ja) 1998-08-06
AU644389B2 (en) 1993-12-09
ES2156852T3 (es) 2001-08-01
CA2069428A1 (en) 1991-05-23
US5854028A (en) 1998-12-29
HU9201712D0 (en) 1992-09-28
EP0504177B1 (en) 2001-02-07
DK66692D0 (da) 1992-05-21
JPH05504560A (ja) 1993-07-15
DK0504177T3 (da) 2001-04-02
KR920703819A (ko) 1992-12-18
JPH104982A (ja) 1998-01-13
US5215895A (en) 1993-06-01
JP2688539B2 (ja) 1997-12-10
WO1991007495A1 (en) 1991-05-30
EP0504177A1 (en) 1992-09-23
DE69033700T2 (de) 2001-09-13
GR3035627T3 (en) 2001-06-29
US6066317A (en) 2000-05-23
DE69033700D1 (de) 2001-03-15
AU6757890A (en) 1991-06-13
KR970005050B1 (ko) 1997-04-11
CA2069428C (en) 2001-07-31

Similar Documents

Publication Publication Date Title
MX9203439A (es) Una citocina mamifera, il-11
BG47033A3 (en) Method for preparing of derivatives of imidazolamine
ES8606289A1 (es) Un procedimiento para la preparacion de piridazinaminas.
NO20064159L (no) Nye, biologisk aktive polypeptider, deres fremstilling og farmasoytiske preparater inneholdende polypeptidene
GB2217718B (en) Recombinant viruses,vaccines containing them and in vitro cell cultures thereof
HK166495A (en) HIV-1 envelope muteins lacking hypervariable domains
MY102472A (en) Preparation of funtional human urokinase proteins.
IT8947794A0 (it) Proteine biologicamente attive, formulazioni che le contengono e metodo per prepararle ed applicarle
IT1196484B (it) Vettore ad espressione e secrezione in lieviti,utile per la preparazione di proteine eterologhe
IT8620691A0 (it) Procedimento di deprotezione di esteri ed eteri allilici, in particolare di derivati di carbapenem.
EP0306219A3 (en) Novel hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
NO922456L (no) Bcrf1-proteiner som inhibitorer av interferon-gamma
ES2058343T3 (es) Piridinas disubstituidas.
DE3585049D1 (de) Monoklonale antikoerper.
ES8900018A1 (es) Procedimiento para la fabricacion de derivados aminoalcoholes peptidicos inhibidores de la renina y de las proteasas acidas
ATE84221T1 (de) Arzneimittel mit methylcellulose.
FI880636A0 (fi) Foerfarande foer inaktivering av med hoelje foersedda virus i en medelst en cell in vitro framstaellda proteinprodukter.
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
FI960839A (fi) Uusia tripeptidejä, jotka ovat käyttökelpoisia immuuni- ja CNS-terapiassa
IT7924358A0 (it) Antibiotici, procedimento per laloro preparazione, e coltura biologicamente pura per impiego in tale procedimento.
DE3675631D1 (de) In-vitro-kulturverfahren.
IT1238207B (it) Preparato vitaminizzato contenente l'enzima lisozima impiegabile in zootecnica e procedimento per la sua produzione.
DK222988D0 (da) Farmaceutiske praeparater indeholdende ornithin-decarboxylase-inhibitorer
IT1053845B (it) Procedimento per l arricchimento di prodotti agricoli in proteine e vitamine
DK0484331T3 (da) Enkeltkrystaller af -g(b)-phenylpropiophenoner